Distinctive behavioral and cellular responses to fluoxetine in the mouse model for Fragile X syndrome

Fluoxetine is used as a therapeutic agent for autism spectrum disorder (ASD), including Fragile X syndrome (FXS). The treatment often associates with disruptive behaviors such as agitation and disinhibited behaviors in FXS. To identify mechanisms that increase the risk to poor treatment outcome, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Uutela, Marko, Lindholm, Jesse, Rantamäki, Tomi, Umemori, Juzoh, Hunter, Kerri, Võikar, Vootele, Castrén, Maija L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036306/
https://www.ncbi.nlm.nih.gov/pubmed/24904293
http://dx.doi.org/10.3389/fncel.2014.00150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036306/
https://www.ncbi.nlm.nih.gov/pubmed/24904293
http://dx.doi.org/10.3389/fncel.2014.00150

Ejemplares similares